231 related articles for article (PubMed ID: 19397004)
1. [Cellular mechanisms of regulation of the inflammatory response in atherosclerosis: the role of cell contact-mediated signaling].
Monaco C; Young S; Paleolog E; Maseri A; Feldmann M
Ital Heart J Suppl; 2001 Apr; 2(4):339-43. PubMed ID: 19397004
[TBL] [Abstract][Full Text] [Related]
2. Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction.
Burger D
Eur Cytokine Netw; 2000 Sep; 11(3):346-53. PubMed ID: 11022117
[TBL] [Abstract][Full Text] [Related]
3. [Immune factors in atherosclerosis].
Pasqui AL; Bova G; Maffei S; Auteri A
Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
[TBL] [Abstract][Full Text] [Related]
4. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins.
Scanu A; Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
J Leukoc Biol; 2008 Apr; 83(4):921-7. PubMed ID: 18223103
[TBL] [Abstract][Full Text] [Related]
5. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques.
Kim WJ; Kang YJ; Suk K; Park JE; Kwon BS; Lee WH
Immunol Invest; 2008; 37(4):359-73. PubMed ID: 18569075
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in atherosclerosis: an update.
Zernecke A; Shagdarsuren E; Weber C
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
[TBL] [Abstract][Full Text] [Related]
8. Anti-atherogenic properties of fibrates may be largely due to their anti-inflammatory effects.
Ye HJ; Zhao SP
Med Hypotheses; 2006; 66(3):495-500. PubMed ID: 16289368
[TBL] [Abstract][Full Text] [Related]
9. Collagens in the progression and complications of atherosclerosis.
Adiguzel E; Ahmad PJ; Franco C; Bendeck MP
Vasc Med; 2009 Feb; 14(1):73-89. PubMed ID: 19144782
[TBL] [Abstract][Full Text] [Related]
10. The role of monocytes in atherosclerotic coronary artery disease.
Pamukcu B; Lip GY; Devitt A; Griffiths H; Shantsila E
Ann Med; 2010 Sep; 42(6):394-403. PubMed ID: 20568979
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
Tedgui A; Mallat Z
Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of atherosclerosis--a brief review.
Kher N; Marsh JD
Semin Thromb Hemost; 2004 Dec; 30(6):665-72. PubMed ID: 15630673
[TBL] [Abstract][Full Text] [Related]
13. T cells in atherogenesis: for better or for worse?
Robertson AK; Hansson GK
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2421-32. PubMed ID: 16973967
[TBL] [Abstract][Full Text] [Related]
14. Update on lipids, inflammation and atherothrombosis.
Badimon L; Storey RF; Vilahur G
Thromb Haemost; 2011 May; 105 Suppl 1():S34-42. PubMed ID: 21479344
[TBL] [Abstract][Full Text] [Related]
15. Chemokine regulation of atherosclerosis.
Barlic J; Murphy PM
J Leukoc Biol; 2007 Aug; 82(2):226-36. PubMed ID: 17329566
[TBL] [Abstract][Full Text] [Related]
16. Cytokines, immuno-inflammatory response and atherosclerosis.
Tedgui A; Bernard C
Eur Cytokine Netw; 1994; 5(3):263-70. PubMed ID: 7948763
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
18. Morphological analysis of cell subpopulations within carotid atherosclerotic plaques.
Businaro R; Digregorio M; Riganò R; Profumo E; Buttari B; Leone S; Salvati B; Capoano R; D'Amati G; Fumagalli L
Ital J Anat Embryol; 2005; 110(2 Suppl 1):109-15. PubMed ID: 16101028
[TBL] [Abstract][Full Text] [Related]
19. The monocyte/macrophage as a therapeutic target in atherosclerosis.
Saha P; Modarai B; Humphries J; Mattock K; Waltham M; Burnand KG; Smith A
Curr Opin Pharmacol; 2009 Apr; 9(2):109-18. PubMed ID: 19230773
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation and atherosclerosis].
Tedgui A; Mallat Z
Nephrologie; 2003; 24(7):411-4. PubMed ID: 14650755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
